September 26, 2011

IMMUNOGEN (IMGN): WHAT TO DO NOW

ImmunoGen (IMGN ) stock has moved up sharply on the news that T-DM1 produced by ImmunoGen improved survival in patients suffering from HER2-Positive Metastatic Breast Cancer.

T-DM1 contains DM1 cancer cell killing agent produced by ImmunoGen attached to an HER-2 targeting antibody.

This development is mostly already in the stock price of ImmunoGen.

If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Buy Change Alert.… Please click here or the title below to read more.

September 26, 2011

FREESCALE SEMICONDUCTOR (FSL): WHAT TO DO NOW

Freescale Semiconductor (FSL) reduced its Q3 revenue guidance. Freescale now projects $1.13 – $1.15 billion compared to consensus of $1.19 billion.

Our analysis shows that this short fall is more likely company specific although Freescale in its statement blamed industry demand.

If and when six screens of the ZYX Change Method are satisfied, we will issue a buy signal on the Real Time Feed of the ZYX Buy Change Alert.… Please click here or the title below to read more.

September 26, 2011

TAKEN MORE PROFITS ON SILVER (SI) (SLV)

Taken profits on our silver futures short position at $28.15 equivalent in silver ETF (SLV) is $30.80.… Please click here or the title below to read more.

September 26, 2011